Systematic Review

A systematic review is a rigorous, transparent secondary research methodology that identifies, appraises, and synthesizes all high-quality empirical studies answering a predefined clinical or scientific question. Unlike narrative reviews, systematic reviews adhere to pre-registered protocols (e.g., PRISMA guidelines), searches across multiple databases, explicit inclusion/exclusion criteria, and standardized risk-of-bias assessments (such as the Cochrane Risk of Bias tool).

Systematic reviews provide the highest level of epidemiological certainty, allowing clinicians to evaluate whether therapeutic outcomes hold across diverse patient demographics and clinical centers.

A single study can be cherry-picked to support almost any claim. Systematic reviews exist to counter that: they search for every relevant study using a pre-specified method, judge each one’s risk of bias, and report what the whole body of evidence shows, including studies with null or negative results. For readers weighing peptide claims, a well-conducted systematic review is often the most efficient summary available.

A systematic review is only as strong as the studies it contains. A 2025 systematic review of BPC-157 in orthopaedic sports medicine identified 544 articles and included 36 studies, but 35 were preclinical and the only human study was small and retrospective. The review was carried out systematically, yet its conclusions rest on low-level evidence. How a review was done and how good its evidence is are separate questions.

Reporting standards help readers judge whether a review was done properly. The PRISMA 2020 statement, a widely used guideline, sets out a 27-item checklist and flow diagrams showing how studies were found, selected and appraised. A review that cannot show its search strategy, inclusion rules and risk-of-bias assessment should be read more like an opinion piece than a systematic review.

“Any review article is a systematic review”

Narrative reviews summarise literature chosen by the authors, often without a stated search method, and can reflect the authors’ own views. A systematic review defines its question, search strategy and inclusion criteria in advance and reports them openly. Some peptide reviews cited online are narrative reviews, occasionally written by the same groups that produced the original studies.

“A systematic review proves a treatment works”

A systematic review summarises evidence; it does not create it. If the included studies are small, biased or done only in animals, the conclusion can only be weak, however carefully the review was conducted. Check what type of studies were included and how the authors rated the certainty of the evidence before accepting its conclusions.

“Systematic review and meta-analysis mean the same thing”

A meta-analysis is a statistical method that pools numerical results from several studies into a single estimate. It is often part of a systematic review, but not always. A systematic review may decide that the available studies are too different to combine and summarise them in words instead, which is common when evidence is sparse.

What is the difference between a systematic review and a literature review?

A traditional literature review, or narrative review, summarises studies the authors select, usually without a reproducible search. A systematic review follows a pre-defined protocol: it searches multiple databases, applies explicit inclusion and exclusion criteria, assesses each study’s risk of bias and documents every step, so that others could repeat it and reach the same set of studies.

What is PRISMA?

PRISMA stands for Preferred Reporting Items for Systematic reviews and Meta-Analyses. It is a reporting guideline, first published in 2009 and updated in 2020, that helps authors explain why a review was done, what they did and what they found. PRISMA 2020 includes a 27-item checklist and flow diagrams showing how studies were identified and selected.

Are there systematic reviews on BPC-157?

Yes. A 2025 systematic review in HSS Journal assessed BPC-157 for musculoskeletal injuries. It found mostly animal studies, one small human study and no clinical safety data, and it noted that BPC-157 lacks FDA approval and is banned in professional sports. The authors described it as promising but warned of risks from unregulated manufacturing and unknown clinical safety.

Where do systematic reviews sit on the evidence pyramid?

Systematic reviews of well-conducted randomised controlled trials usually sit at the top of evidence hierarchies, because they combine the strongest study design with a complete, transparent search. A systematic review of animal or observational studies does not inherit that status automatically; its strength depends on the quality and type of the studies it includes.